 Manesha Putra
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 8 | 2026 | 295 | 2.430 |
Why?
| | Fetal Growth Retardation | 7 | 2026 | 593 | 2.150 |
Why?
| | Fetal Heart | 3 | 2026 | 56 | 1.900 |
Why?
| | Hemoglobinopathies | 2 | 2022 | 6 | 1.330 |
Why?
| | Pregnancy | 21 | 2026 | 7216 | 1.220 |
Why?
| | Myocardial Contraction | 3 | 2026 | 293 | 1.220 |
Why?
| | Fetal Weight | 3 | 2024 | 53 | 1.030 |
Why?
| | Obstetrics | 2 | 2020 | 177 | 0.980 |
Why?
| | Fetus | 4 | 2025 | 804 | 0.970 |
Why?
| | Chorionic Villi Sampling | 1 | 2025 | 4 | 0.880 |
Why?
| | Potassium Chloride | 1 | 2024 | 40 | 0.850 |
Why?
| | Long QT Syndrome | 1 | 2025 | 68 | 0.840 |
Why?
| | Umbilical Veins | 1 | 2024 | 58 | 0.840 |
Why?
| | Bartter Syndrome | 1 | 2023 | 7 | 0.820 |
Why?
| | Polyhydramnios | 1 | 2023 | 17 | 0.810 |
Why?
| | Corpus Callosum | 1 | 2024 | 72 | 0.800 |
Why?
| | Infant, Small for Gestational Age | 4 | 2026 | 118 | 0.790 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 119 | 0.750 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 273 | 0.730 |
Why?
| | Abortion, Induced | 1 | 2024 | 112 | 0.710 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 115 | 0.700 |
Why?
| | Premature Birth | 2 | 2023 | 390 | 0.690 |
Why?
| | Health Care Rationing | 1 | 2020 | 56 | 0.610 |
Why?
| | Resource Allocation | 1 | 2020 | 52 | 0.600 |
Why?
| | Eligibility Determination | 1 | 2019 | 72 | 0.580 |
Why?
| | Delivery, Obstetric | 1 | 2020 | 160 | 0.570 |
Why?
| | Genetics, Medical | 1 | 2017 | 23 | 0.530 |
Why?
| | Monosomy | 1 | 2017 | 10 | 0.530 |
Why?
| | Pre-Eclampsia | 1 | 2019 | 206 | 0.500 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 644 | 0.480 |
Why?
| | Aspirin | 1 | 2019 | 406 | 0.470 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 440 | 0.450 |
Why?
| | Gynecology | 1 | 2017 | 181 | 0.440 |
Why?
| | Female | 23 | 2026 | 79045 | 0.420 |
Why?
| | Gestational Age | 3 | 2026 | 990 | 0.370 |
Why?
| | Genomics | 1 | 2017 | 830 | 0.360 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1582 | 0.340 |
Why?
| | Down Syndrome | 1 | 2017 | 525 | 0.320 |
Why?
| | Adult | 13 | 2025 | 40881 | 0.310 |
Why?
| | Prenatal Care | 2 | 2023 | 309 | 0.310 |
Why?
| | Humans | 23 | 2026 | 145783 | 0.300 |
Why?
| | Hospitalization | 1 | 2020 | 2461 | 0.300 |
Why?
| | Echocardiography | 2 | 2025 | 648 | 0.280 |
Why?
| | Infant, Newborn | 5 | 2025 | 6465 | 0.270 |
Why?
| | Prospective Studies | 3 | 2026 | 8078 | 0.270 |
Why?
| | Pregnancy Trimester, Third | 2 | 2025 | 119 | 0.260 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 196 | 0.250 |
Why?
| | Internship and Residency | 1 | 2017 | 1269 | 0.250 |
Why?
| | Retrospective Studies | 6 | 2025 | 17330 | 0.230 |
Why?
| | ERG1 Potassium Channel | 1 | 2025 | 6 | 0.230 |
Why?
| | Ultrasonography, Doppler | 1 | 2025 | 126 | 0.220 |
Why?
| | Uterine Artery | 1 | 2025 | 74 | 0.210 |
Why?
| | Sample Size | 1 | 2025 | 121 | 0.210 |
Why?
| | Bed Rest | 1 | 2024 | 14 | 0.210 |
Why?
| | Cerebellar Vermis | 1 | 2024 | 5 | 0.210 |
Why?
| | Pregnancy Trimester, Second | 1 | 2024 | 85 | 0.210 |
Why?
| | Heart Atria | 1 | 2025 | 141 | 0.200 |
Why?
| | Middle Cerebral Artery | 1 | 2024 | 56 | 0.200 |
Why?
| | Injections | 1 | 2024 | 199 | 0.200 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.200 |
Why?
| | Fetal Death | 1 | 2023 | 58 | 0.200 |
Why?
| | Cerebellar Ataxia | 1 | 2023 | 13 | 0.200 |
Why?
| | Fetal Development | 2 | 2024 | 298 | 0.200 |
Why?
| | Cohort Studies | 2 | 2024 | 6033 | 0.190 |
Why?
| | Blood Flow Velocity | 1 | 2024 | 421 | 0.190 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 271 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 426 | 0.160 |
Why?
| | Maternal Mortality | 1 | 2020 | 53 | 0.150 |
Why?
| | Cell Line | 1 | 2025 | 2823 | 0.150 |
Why?
| | Monte Carlo Method | 1 | 2020 | 148 | 0.150 |
Why?
| | Fertility Preservation | 1 | 2020 | 55 | 0.150 |
Why?
| | Heart Ventricles | 1 | 2024 | 756 | 0.150 |
Why?
| | Aneuploidy | 1 | 2019 | 91 | 0.150 |
Why?
| | United States | 4 | 2020 | 16126 | 0.140 |
Why?
| | Forecasting | 1 | 2020 | 390 | 0.140 |
Why?
| | American Heart Association | 1 | 2019 | 358 | 0.130 |
Why?
| | Karyotyping | 1 | 2017 | 106 | 0.130 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2017 | 43 | 0.130 |
Why?
| | Chromosome Deletion | 1 | 2017 | 126 | 0.130 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2020 | 188 | 0.130 |
Why?
| | Cervix Uteri | 1 | 2017 | 50 | 0.130 |
Why?
| | Parents | 1 | 2025 | 1407 | 0.120 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2017 | 328 | 0.120 |
Why?
| | Body Mass Index | 1 | 2025 | 2447 | 0.120 |
Why?
| | Abnormalities, Multiple | 1 | 2017 | 199 | 0.120 |
Why?
| | Hypoxia | 1 | 2023 | 1199 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2020 | 712 | 0.110 |
Why?
| | Universities | 1 | 2017 | 445 | 0.110 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 583 | 0.100 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 883 | 0.100 |
Why?
| | Incidence | 1 | 2020 | 2934 | 0.090 |
Why?
| | Blood Pressure | 1 | 2019 | 1782 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2019 | 3634 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2017 | 603 | 0.080 |
Why?
| | Hypertension | 1 | 2019 | 1276 | 0.080 |
Why?
| | Curriculum | 1 | 2017 | 1074 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5925 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3170 | 0.070 |
Why?
| | Child, Preschool | 1 | 2023 | 11868 | 0.070 |
Why?
| | Risk Factors | 1 | 2019 | 10919 | 0.050 |
Why?
| | Neoplasms | 1 | 2020 | 2913 | 0.050 |
Why?
| | Biometry | 1 | 2024 | 66 | 0.050 |
Why?
| | Organ Size | 1 | 2025 | 461 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2023 | 29 | 0.050 |
Why?
| | Head | 1 | 2024 | 123 | 0.050 |
Why?
| | Immunogenicity, Vaccine | 1 | 2022 | 37 | 0.040 |
Why?
| | Mutation, Missense | 1 | 2023 | 335 | 0.040 |
Why?
| | Workflow | 1 | 2023 | 183 | 0.040 |
Why?
| | Antibody Formation | 1 | 2022 | 288 | 0.040 |
Why?
| | Male | 3 | 2025 | 73010 | 0.040 |
Why?
| | Genetic Testing | 1 | 2023 | 483 | 0.040 |
Why?
| | Fertility | 1 | 2020 | 174 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 674 | 0.030 |
Why?
| | Cervical Length Measurement | 1 | 2017 | 5 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2022 | 892 | 0.030 |
Why?
| | Databases, Factual | 1 | 2022 | 1491 | 0.030 |
Why?
| | Risk | 1 | 2017 | 923 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1428 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2020 | 948 | 0.020 |
Why?
| | Registries | 1 | 2022 | 2410 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3418 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6085 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 14254 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 22577 | 0.010 |
Why?
| | Child | 1 | 2020 | 22740 | 0.010 |
Why?
| | Animals | 1 | 2022 | 38101 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 36309 | 0.010 |
Why?
|
|
Putra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|